This association might protect the NPDR patients from progression to the proliferative stage even after long-lasting diabetes because of elevating circulating HIF-1α Pro582Ser which is known to be resistant to hyperglycemia and hyperlipidemia. This evidence concerns the gene HIF1A and hyperlipidemia.